Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location:Home > Pharma China Web Edition > Feature Articles    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905
Email:
info@pharmachinaonline.com

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Email:
info@pharmachinaonline.com
 
 
 
Feature Articles
 
WSJ: Drug Industry’s China Habit Will Take Time to Kick 8/7/2020
Navigating The Latest Challenges Of China's Human Genetic Resourc... 8/6/2020
China To Strengthen Regulation Of Human Genetic Resources 8/6/2020
Review of Chinese Pharma Deals, R&D and Regulatory Developments i... 8/5/2020
Uncertainties Persist amid Conflicting Signals as China Intensifi... 8/1/2020
China's Proposals to Provide a Patent Linkage System and Patent T... 7/29/2020
China: Looking Back at 2019's Main IP Developments and Looking Fo... 7/28/2020
New Draft Patent Law - What To Expect and What Not to Expect 7/16/2020
Long Awaited Chinese Civil Code - Impacts on IPR 7/14/2020
China's Latest Patent Law Amendment Introduces Patent Linkage And... 7/14/2020
Revisiting the Basis of Your China Strategy in the Post-Covid New... 7/1/2020
Trends in U.S. Multinational Enterprise Activity in China, 2000-2... 7/1/2020
Ex-USPTO Head, Retired Judge Back China Pharma IP Reform 6/30/2020
How Data Protection Matters for Pharma Cos in Mainland China? - E... 6/30/2020
In Depth: Decoding China's First Civil Code 6/23/2020
Dealing with the Chinese Economy after COVID-19 6/3/2020
Chinese Antitrust Authority Imposes Maximum Fine In Rare Abuse Of... 6/1/2020
Despite Stormy Days Ahead, Pockets of Hope and Opportunity Remain... 6/1/2020
Challenges Posed to Chinese Biotechs in Post-Pandemic Era 5/28/2020
Considerations on the Protection of Remdesivir under Trademark La... 5/26/2020
COVID-19 Makes Digital Care the Norm in China 5/21/2020
As China Stumbles, India Plans Big Exports Push in Bulk Drugs 5/20/2020
Trump Is Investing Millions to Bring Drug Making Back to US From ... 5/20/2020
How the Coronavirus Is Helping to Fix China’s Broken Healthcare ... 5/19/2020
China's Role in The Global Biotechnology Sector and Implications ... 5/14/2020
Strategic Considerations for Pharma MNCs in the Post-Coronavirus ... 5/1/2020
COVID-19 Is Reshaping the Pharmaceutical Supply Chain 4/27/2020
SAMR Continues Focus on Pharma Sector Amid Covid-19 Outbreak, Fin... 4/23/2020
New Report: Cascading Economic Impacts of the COVID-19 Outbreak i... 4/21/2020
Coronavirus Puts Big Pharma’s IP Regime to the Test 4/21/2020
Page:1/5  Total number of articles:131  [1][2][3][4][5]

 
 
 
 
© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links